Literature DB >> 18818246

Endothelium-dependent contractions: when a good guy turns bad!

Paul M Vanhoutte1, Eva H C Tang.   

Abstract

Endothelial cells can induce contractions of the underlying vascular smooth muscle by generating vasoconstrictor prostanoids (endothelium-dependent contracting factor; EDCF). The endothelial COX-1 isoform of cyclooxygenase appears to play the dominant role in the phenomenon. Its activation requires an increase in intracellular Ca(2+) concentration. The production of EDCF is inhibited acutely and chronically by nitric oxide (NO), and possibly by endothelium-dependent hyperpolarizing factor (EDHF). The main prostanoids involved in endothelium-dependent contractions appear to be endoperoxides (PGH(2)) and prostacyclin, which activate thromboxane-prostanoid (TP) receptors of the vascular smooth muscle cells. Oxygen-derived free radicals can facilitate the production and/or the action of EDCF. Endothelium-dependent contractions are exacerbated by ageing, obesity, hypertension and diabetes, and thus are likely to contribute to the endothelial dysfunction observed in older people and in essential hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818246      PMCID: PMC2655387          DOI: 10.1113/jphysiol.2008.161430

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  105 in total

1.  Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.

Authors:  S Taddei; A Virdis; L Ghiadoni; A Magagna; A Salvetti
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

2.  Mechanisms of hypoxic vasoconstriction in the canine isolated pulmonary artery: role of endothelium and sodium pump.

Authors:  Y Hoshino; K J Morrison; P M Vanhoutte
Journal:  Am J Physiol       Date:  1994-08

3.  Role of superoxide anions in the mediation of endothelium-dependent contractions.

Authors:  F Cosentino; J C Sill; Z S Katusić
Journal:  Hypertension       Date:  1994-02       Impact factor: 10.190

4.  Purinergic endothelium-dependent and -independent contractions in rat aorta.

Authors:  J V Mombouli; P M Vanhoutte
Journal:  Hypertension       Date:  1993-10       Impact factor: 10.190

5.  Aging and endothelial function in normotensive subjects and patients with essential hypertension.

Authors:  S Taddei; A Virdis; P Mattei; L Ghiadoni; A Gennari; C B Fasolo; I Sudano; A Salvetti
Journal:  Circulation       Date:  1995-04-01       Impact factor: 29.690

6.  Contractions to endothelin in normotensive and spontaneously hypertensive rats: role of endothelium and prostaglandins.

Authors:  W Auch-Schwelk; P M Vanhoutte
Journal:  Blood Press       Date:  1992-05       Impact factor: 2.835

7.  Role of endothelium in endothelin-evoked contractions in the rat aorta.

Authors:  S Taddei; P M Vanhoutte
Journal:  Hypertension       Date:  1993-01       Impact factor: 10.190

8.  Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat.

Authors:  C M Boulanger; K J Morrison; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

9.  Prostaglandin H2 as an endothelium-derived contracting factor modulates endothelin-1-induced contraction.

Authors:  H Asano; K Shimizu; M Muramatsu; Y Iwama; Y Toki; Y Miyazaki; K Okumura; H Hashimoto; T Ito
Journal:  J Hypertens       Date:  1994-04       Impact factor: 4.844

Review 10.  Free radicals in diabetic endothelial cell dysfunction.

Authors:  B Tesfamariam
Journal:  Free Radic Biol Med       Date:  1994-03       Impact factor: 7.376

View more
  49 in total

Review 1.  Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets.

Authors:  Michel Félétou; Ralf Köhler; Paul M Vanhoutte
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 2.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

Review 3.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

Review 4.  Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction.

Authors:  Matthias Barton; Oliver Baretella; Matthias R Meyer
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  The endothelial saga: the past, the present, the future.

Authors:  Dragomir N Serban; Bernd Nilius; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-03-07       Impact factor: 3.657

Review 6.  Endothelial dysfunction: a strategic target in the treatment of hypertension?

Authors:  Eva H C Tang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-02-02       Impact factor: 3.657

Review 7.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

8.  Contribution of sympathetic activation to coronary vasodilatation during the cold pressor test in healthy men: effect of ageing.

Authors:  Kevin D Monahan; Robert P Feehan; Lawrence I Sinoway; Zhaohui Gao
Journal:  J Physiol       Date:  2013-03-11       Impact factor: 5.182

9.  Activation of NQO-1 mediates the augmented contractions of isolated arteries due to biased activity of soluble guanylyl cyclase in their smooth muscle.

Authors:  Charlotte M S Detremmerie; Susan W S Leung; Paul M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-30       Impact factor: 3.000

Review 10.  Cellular signaling and NO production.

Authors:  Thomas Michel; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-01-16       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.